
Europe Protein Expression Systems Market Size, Share, By Product Type (Reagents, Expression Vectors/Plasmids, Competent Cells and Instruments), System Type (Prokaryotic Expression Systems, and Eukaryotic Expression Systems), Application (Therapeutic Prote
Description
Europe Protein Expression Systems Market Size, Share, By Product Type (Reagents, Expression Vectors/Plasmids, Competent Cells and Instruments), System Type (Prokaryotic Expression Systems, and Eukaryotic Expression Systems), Application (Therapeutic Protein Production, Research Applications, Industrial Enzymes, Diagnostics, and Others), End User (Pharmaceutical and Contract Research Organizations, Academic and Research Institutes, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), and Others), Trends, Analysis, and Forecast till 2035
The Europe Protein Expression Systems Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
The Europe protein expression systems market produces functional proteins in multiple host cells with integration of technologies in host cells which is an important key aspect for biotechnology and drug development. Large scale production of enzymes, and vaccines, and therapeutic proteins along with research activities that include supporting functional genomics, structural biology and molecular biology.
Report Highlights:
In April 2024, the J.CHO High Expression System, was released by Just – Evotec Biologics as this platform is engineered for the continuous manufacturing of complex antibody formats, including monoclonal antibodies, Fc-fusions, and bispecific antibodies.
In October 2023, ESF AdvanCD was introduced by Expression Systems which is a chemically defined, animal-origin-free, protein-free, and serum-free insect cell culture medium tailored for applications like viral vector manufacturing and structural biology, aiming to deliver superior protein expression yields while ensuring consistency and scalability in production.
Report Analysis:
Trends in Europe Protein Expression Systems Market:
Key trends and opportunities in Europe protein expression systems market include higher demand for protein-based medicines to treat a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. High specificity and effectiveness of protein expression systems make them ideal for targeted therapies. The reliance on therapeutic proteins increases as the global burden of chronic and complex diseases continues to rise where the monoclonal antibodies, hormones, and enzymes is highly adopted driving further the expansion of the protein expression systems market in the region.
Segmentation:
By Product Type:
Yell Business
IBA Lifesciences GmbH?
Lonza
Merck KGaA
Jena Bioscience GmbH
Takara Bio Inc
ProteoGenix
ARTES Biotechnology GmbH
Biosynth
Icosagen
Eurofins Genomics
Thermo Fisher Scientific Inc.
Agilent Technologies
Bio-Rad Laboratories, Inc.
QIAGEN
What Our Report Offers:
FAQs:
Key Questions Answered in the Report.
1. What was the Europe Protein Expression Systems Market size in 2025?
2. What is projected growth rate of the Europe Protein Expression Systems Market during 2025-2035?
3. What are the key factors driving the Europe Protein Expression Systems Market growth?
4. What are leading players in the Europe Protein Expression Systems Market?
5. What are the key regions analyzed in the Europe Protein Expression Systems Market?
6. Which region is dominating in the Europe Protein Expression Systems Market?
The Europe Protein Expression Systems Market Report offers an in-depth exploration of emerging market trends, driving factors, challenges, and key segments that shape the industry. It includes a thorough examination of regulatory frameworks, company profiles, and the latest industry developments. The report delves into product development, positioning strategies, and the impact of new technologies on the market landscape. By identifying challenges and opportunities, the report provides a detailed roadmap for market growth.
The Europe protein expression systems market produces functional proteins in multiple host cells with integration of technologies in host cells which is an important key aspect for biotechnology and drug development. Large scale production of enzymes, and vaccines, and therapeutic proteins along with research activities that include supporting functional genomics, structural biology and molecular biology.
Report Highlights:
- Europe protein expression systems market size is accounted for USD 1.9 Billion in 2025.
- Target market size is estimated to be valuated at USD 5.3 Billion by 2035 and at a registered CAGR of 10.23%.
- By Product type, Reagents is the dominant product segment is projected to govern the Europe protein expression systems market share.
- By Application, the therapeutic protein production segment is expected to influence the Europe protein expression systems market share.
- By end-user, the pharmaceutical and biotechnology companies is the end user ruling over the Europe protein expression systems market size.
In April 2024, the J.CHO High Expression System, was released by Just – Evotec Biologics as this platform is engineered for the continuous manufacturing of complex antibody formats, including monoclonal antibodies, Fc-fusions, and bispecific antibodies.
In October 2023, ESF AdvanCD was introduced by Expression Systems which is a chemically defined, animal-origin-free, protein-free, and serum-free insect cell culture medium tailored for applications like viral vector manufacturing and structural biology, aiming to deliver superior protein expression yields while ensuring consistency and scalability in production.
Report Analysis:
Trends in Europe Protein Expression Systems Market:
Key trends and opportunities in Europe protein expression systems market include higher demand for protein-based medicines to treat a wide range of diseases, including cancer, autoimmune disorders, and infectious diseases. High specificity and effectiveness of protein expression systems make them ideal for targeted therapies. The reliance on therapeutic proteins increases as the global burden of chronic and complex diseases continues to rise where the monoclonal antibodies, hormones, and enzymes is highly adopted driving further the expansion of the protein expression systems market in the region.
Segmentation:
By Product Type:
- Reagents
- Expression Vectors/Plasmids
- Competent Cells
- Instruments
- Prokaryotic Expression Systems
- Eukaryotic Expression Systems
- Therapeutic Protein Production
- Research Applications
- Industrial Enzymes
- Diagnostics
- Others
- Pharmaceutical and Contract Research Organizations
- Academic and Research Institutes
- Contract Research Organizations (CROs)
- Contract Manufacturing Organizations (CMOs)
- Others
Yell Business
IBA Lifesciences GmbH?
Lonza
Merck KGaA
Jena Bioscience GmbH
Takara Bio Inc
ProteoGenix
ARTES Biotechnology GmbH
Biosynth
Icosagen
Eurofins Genomics
Thermo Fisher Scientific Inc.
Agilent Technologies
Bio-Rad Laboratories, Inc.
QIAGEN
What Our Report Offers:
- Regional & Country-Specific Market Intelligence: Gain a competitive edge with in-depth market share breakdowns across critical regions and nations, helping you identify growth opportunities and strategic positioning.
- Strategic Entry Support for New Entrants: Expert-backed recommendations to navigate market entry challenges, establish a strong presence, and accelerate growth in unfamiliar markets.
- Accurate Long-Term Market Projections: Trusted forecasts spanning 2025 to 2035, including key milestones for 2025, 2026, and 2030, empowering data-driven decision-making for sustainable investments.
- Comprehensive Market Trend Analysis: A deep dive into market drivers, barriers, emerging opportunities, and potential risks, alongside insights into high-growth investment areas and industry challenges.
- Actionable Business Strategies: Data-powered recommendations customized for key market segments, supported by rigorous market assessments to maximize profitability.
- Competitive Landscape Mapping: Uncover prevailing industry trends, competitor tactics, and untapped opportunities to refine your market approach and stay ahead.
- Exclusive Company Profiles: Detailed evaluations of leading market players, covering business models, financial health, strategic moves, and recent advancements.
- Next-Gen Supply Chain Trends: Cutting-edge insights into technological innovations revolutionizing supply chain operations, enhancing efficiency, and reducing costs.
FAQs:
Key Questions Answered in the Report.
1. What was the Europe Protein Expression Systems Market size in 2025?
2. What is projected growth rate of the Europe Protein Expression Systems Market during 2025-2035?
3. What are the key factors driving the Europe Protein Expression Systems Market growth?
4. What are leading players in the Europe Protein Expression Systems Market?
5. What are the key regions analyzed in the Europe Protein Expression Systems Market?
6. Which region is dominating in the Europe Protein Expression Systems Market?
Table of Contents
165 Pages
- Europe Protein Expression Systems Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By System Type
- Market Snippet, By Application
- Market Snippet, By End Use
- Market Snippet, By Country
- Opportunity Map Analysis
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Type Launch
- Merger and Acquisitions
- Impact Analysis
- PEST Analysis
- Porter’s Analysis
- Collaboration and Partnerships
- New Product Launch
- Market Segmentation, By Product Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Reagents
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Expression Vectors/Plasmids
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Competent Cells
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Instruments
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By System Type, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Prokaryotic Expression Systems
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Eukaryotic Expression Systems
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Application, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Therapeutic Protein Production
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Research Applications
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Industrial Enzymes
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Diagnostics
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Others
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By End Use, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Segment Trends
- Pharmaceutical and Contract Research Organizations
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Academic and Research Institutes
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Contract Research Organizations (CROs)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Contract Manufacturing Organizations (CMOs)
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Other
- Overview
- Market Size and Forecast (USD Bn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
- Market Segmentation, By Country, Forecast Period up to 10 Years, (USD Bn)
- Overview
- Market Value and Forecast (USD Bn), and Share Analysis (%), Forecast Period up to 10 Years
- Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
- Regional Trends
- Europe
- Market Size and Forecast (USD Bn), By Product Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By System Type, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Application, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By End User, Forecast Period up to 10 Years
- Market Size and Forecast (USD Bn), By Country, Forecast Period up to 10 Years
- By Country:
- Germany
- U.K.
- France
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.